HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)

CNY 7.11

(-0.28%)

EBITDA Summary of HPGC Renmintongtai Pharmaceutical Corporation

  • HPGC Renmintongtai Pharmaceutical Corporation's latest annual EBITDA in 2023 was 474.3 Million CNY , up 7.13% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation's latest quarterly EBITDA in 2024 Q3 was 98.86 Million CNY , up 2.07% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported an annual EBITDA of 442.75 Million CNY in 2022, down -7.92% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported an annual EBITDA of 469.35 Million CNY in 2021, up 66.73% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a quarterly EBITDA of 98.86 Million CNY for 2024 Q3, up 2.07% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported a quarterly EBITDA of 112.53 Million CNY for 2024 Q1, up 6.83% from previous quarter.

Annual EBITDA Chart of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1990)

Historical Annual EBITDA of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1990)

Year EBITDA EBITDA Growth
2023 474.3 Million CNY 7.13%
2022 442.75 Million CNY -7.92%
2021 469.35 Million CNY 66.73%
2020 275.35 Million CNY -36.73%
2019 413.1 Million CNY 19.08%
2018 382.76 Million CNY 0.62%
2017 382.43 Million CNY -4.92%
2016 344.94 Million CNY 8.1%
2015 296.34 Million CNY 64.32%
2014 225.23 Million CNY 12.8%
2013 128.04 Million CNY -66.59%
2012 571.9 Million CNY -0.22%
2011 581.06 Million CNY 17.15%
2010 499.36 Million CNY 18.8%
2009 417.77 Million CNY -5.87%
2008 437.48 Million CNY 20.63%
2007 370.56 Million CNY 21.59%
2006 310.54 Million CNY 2.8%
2005 303.26 Million CNY 216.48%
2004 95.82 Million CNY 20.27%
2003 79.67 Million CNY 3.74%
2002 76.79 Million CNY -27.4%
2001 105.78 Million CNY -10.43%
2000 118.1 Million CNY 229.34%
1999 35.78 Million CNY -10.81%
1998 34.96 Million CNY 228.63%
1997 12.23 Million CNY 92.2%
1996 6.36 Million CNY -38.49%
1995 10.34 Million CNY -96.26%
1994 276.45 Million CNY 600.05%
1993 39.49 Million CNY 43.73%
1992 27.47 Million CNY 27.18%
1991 21.6 Million CNY 36.97%
1990 15.77 Million CNY 0.0%

Peer EBITDA Comparison of HPGC Renmintongtai Pharmaceutical Corporation

Name EBITDA EBITDA Difference
Shanghai Haoyuan Chemexpress Co., Ltd. 275.11 Million CNY -72.401%
Hubei Jumpcan Pharmaceutical Co., Ltd. 3.61 Billion CNY 86.888%
Yabao Pharmaceutical Group Co., Ltd 391.76 Million CNY -21.069%
Shandong Lukang Pharmaceutical Co.,Ltd. 741.88 Million CNY 36.068%
Zhejiang Huahai Pharmaceutical Co., Ltd. 2.15 Billion CNY 77.995%
Tasly Pharmaceutical Group Co., Ltd 1.95 Billion CNY 75.733%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 971.82 Million CNY 51.195%
Lionco Pharmaceutical Group Co.,Ltd. -90.79 Million CNY 622.416%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 111.25 Million CNY -326.329%
China Animal Husbandry Industry Co., Ltd. 677.63 Million CNY 30.006%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 743.16 Million CNY 36.178%
Zhejiang Shengda Bio-Pharm Co., Ltd. 34.44 Million CNY -1276.828%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 479.02 Million CNY 0.985%
Henan Lingrui Pharmaceutical Co., Ltd. 736.53 Million CNY 35.603%
Guizhou Yibai Pharmaceutical Co., Ltd. 355.07 Million CNY -33.58%
Zhongzhu Healthcare Holding Co.,Ltd -234.13 Million CNY 302.581%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 186.48 Million CNY -154.333%
Jianmin Pharmaceutical Group Co.,Ltd. 615.11 Million CNY 22.892%
North China Pharmaceutical Company Ltd. 1.51 Billion CNY 68.745%
CanSino Biologics Inc. -1.64 Billion CNY 128.803%
Zhejiang Hisun Pharmaceutical Co., Ltd. 1.18 Billion CNY 59.814%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 840.85 Million CNY 43.593%
ChengDu ShengNuo Biotec Co.,Ltd. 121.76 Million CNY -289.54%
Dali Pharmaceuticalco.,Ltd 360.83 Thousand CNY -131348.092%
Harbin Pharmaceutical Group Co., Ltd. 1.02 Billion CNY 53.699%
Zhejiang Medicine Co., Ltd. 1.13 Billion CNY 58.258%
Humanwell Healthcare (Group) Co.,Ltd. 4.55 Billion CNY 89.595%
Ginwa Enterprise (Group) Inc. -3.67 Million CNY 13005.421%
KPC Pharmaceuticals, Inc. 801.81 Million CNY 40.846%
Changchun BCHT Biotechnology Co. 662.93 Million CNY 28.454%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 265.55 Million CNY -78.611%
Ningbo Menovo Pharmaceutical Co., Ltd. 155.45 Million CNY -205.115%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 1.59 Billion CNY 70.306%
Nanjing Well Pharmaceutical Group Co.,Ltd. 209.72 Million CNY -126.156%
Joincare Pharmaceutical Group Industry Co.,Ltd. 5.01 Billion CNY 90.539%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 2.21 Billion CNY 78.631%
Chongqing Taiji Industry(Group) Co.,Ltd 1.6 Billion CNY 70.394%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 6.45 Billion CNY 92.656%
China National Medicines Corporation Ltd. 2.82 Billion CNY 83.216%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 267.44 Million CNY -77.348%
Shenzhen Chipscreen Biosciences Co., Ltd. 187.43 Million CNY -153.043%
Beijing Tongrentang Co., Ltd 4.09 Billion CNY 88.426%
Tibet Weixinkang Medicine Co., Ltd. 266.6 Million CNY -77.905%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 5.55 Billion CNY 91.468%
Hunan Fangsheng Pharmaceutical Co., Ltd. 310.08 Million CNY -52.957%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 348.84 Million CNY -35.964%
Shanghai Jiaoda Onlly Co.,Ltd 17.57 Million CNY -2598.222%
Jiang Zhong Pharmaceutical Co.,Ltd 1.03 Billion CNY 53.96%
Guobang Pharma Ltd. 1.04 Billion CNY 54.454%
Mayinglong Pharmaceutical Group Co., LTD. 633.25 Million CNY 25.1%
Cisen Pharmaceutical Co., Ltd. 840.03 Million CNY 43.537%
Hunan Warrant Pharmaceutical Co.,Ltd 292.03 Million CNY -62.412%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 3.22 Million CNY -14585.198%
Shandong Buchang Pharmaceuticals Co., Ltd. 1.09 Billion CNY 56.733%
Zhejiang Starry Pharmaceutical Co.,Ltd. 327.5 Million CNY -44.821%
Kangmei Pharmaceutical Co., Ltd. 536.71 Million CNY 11.629%
Henan Taloph Pharmaceutical Stock Co.,Ltd 111.8 Million CNY -324.212%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 565.74 Million CNY 16.162%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd -57.84 Million CNY 919.966%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 250.5 Million CNY -89.34%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.97 Billion CNY 76.023%
Shanghai Yizhong Pharmaceutical Co., Ltd. 195.4 Million CNY -142.733%
Tibet Rhodiola Pharmaceutical Holding Co. 976.16 Million CNY 51.411%
Sichuan Huiyu Pharmaceutical Co., Ltd. 203.49 Million CNY -133.077%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 259.87 Million CNY -82.51%